Roche (RHHBY) To Invest $535M, Create 3,500 Jobs At New Swiss IT Site
Novo Nordisk A/S (NVO) May Add Hundreds To R&D Staff For Obesity Medicines
Gilead Sciences, Inc. (GILD)'s Experimental Drug Simtuzumab Fails Mid-Stage Study
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer
South San Francisco's Sutro Biopharma Forges $298 Million Antibody Drug Pact With Merck KGaA (MKGAF.PK)
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA)
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal
Moving On From A Botched Novartis AG (NVS) Deal, Proteon Therapeutics, Inc. Turns To Plan B: IPO
Tokai Pharmaceuticals Bags $97 Million For Prostate Cancer Drug In Upsized IPO
Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants?
Looming Patent Deadline Pushes Sanofi (France) (SAN.PA) To Be More Aggressive; Wants To Add Oral GLP-1 To Diabetes Offering
Analyst: Gilead Sciences, Inc. (GILD) Still A Buy After Cancer Drug Fail
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Buys Rights To Tildrakizumab From Merck & Co. (MRK) For An Upfront Payment Of $80 Million
Johnson & Johnson (JNJ)'s Biggest Plant Coming Up In Telangana
Swiss Biopharma Cardiorentis Enters Euro 45 Million Financing Deal
Regeneron Pharmaceuticals, Inc. (REGN) Wins Breakthrough Therapy Designation From FDA For EYLEA
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug
Takeda Pharmaceutical Co. Ltd. (TKPYY) To Headquarter Global Oncology Unit In Crowded Cambridge
See All News >
See All News >
//-->